Clinical Trials Sponsored by Pacific Parkinson's Research Centre

Total 98 results

Pacific Parkinson's Research Centre

Completed

The Effects of Exercise in Parkinson's Disease (PET)

Parkinson Disease 10

Canada
Pacific Parkinson's Research Centre

Completed

Single Exercise Bout in Parkinson's Disease (PD)

Parkinson Disease

Canada
Pacific Parkinson's Research Centre

Terminated

Parkinson's Disease Exercise TMS PET Study

Parkinson Disease

Canada
Pacific Parkinson's Research Centre

Terminated

tDCS in Parkinson's Disease With Depression

Depression | Parkinson's

Canada
Pacific Parkinson's Research Centre
University of British Columbia

Recruiting

Somatotopy in Parkinson's Disease

Parkinson Disease

Canada
Pacific Parkinson's Research Centre
Natural Sciences and Engineering Research Council, Canada

Recruiting

Exercise & Brain Energetics in PD (EBEPD)

Parkinson Disease

Canada
California Pacific Medical Center Research Institute
California Pacific Medical Center

Completed

The PERFusion Use in Stroke Evaluation Study (PERFUSE)

Ischemic Stroke

United States
California Pacific Medical Center Research Institute
Pacific Vision Foundation

Completed

A Pilot Project to Assess the Impact of Diabetes Education During Ophthalmology Visits (LionsDMed)

Diabetes Complications | Diabetic Retinopathy
Ryan D'Arcy
University of British Columbia; Pacific Parkinson's Research Institute

Recruiting

Multimodal Neuromodulation in Individuals With Parkinson's Disease

Parkinson Disease

Canada
California Pacific Medical Center Research Institute

Completed

A Randomized, Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence

Methamphetamine Dependence

United States
California Pacific Medical Center Research Institute

Completed

A Pilot Trial of Dextroamphetamine for Methamphetamine Dependence (1D)

Methamphetamine Addiction

United States
California Pacific Medical Center Research Institute

Completed

Placebo Controlled Study of Sublingual Salvinorin A (6A)

Pharmaceutical Preparations
California Pacific Medical Center Research Institute

Completed

Study of the Effects of MDMA/Ecstasy on Water Regulation, Sleep, and Cognition. (2C)

MDMA Discontinuation Syndrome

United States
California Pacific Medical Center Research Institute

Unknown

A Dose Ranging Study of Modafinil for Methamphetamine Dependence

Substance Dependence | Amphetamine Dependence

United States
California Pacific Medical Center Research Institute

Recruiting

Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions

Gastrointestinal Neoplasms | Benign Neoplasm of Intestinal Tract

United States
California Pacific Medical Center Research Institute

Completed

CPMC Early Undifferentiated Arthritis Registry (CEUAR)

Early Undifferentiated Arthritis

United States
California Pacific Medical Center Research Institute

Unknown

A Cognitive Behavioral Therapy-Based Text Message Intervention for Methamphetamine Dependence

Amphetamine-Related Disorders

United States
California Pacific Medical Center Research Institute

Completed

Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects (AIKO-150)

Opiate Addiction

United States
California Pacific Medical Center Research Institute

Recruiting

A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma

Uveal Melanoma

United States
California Pacific Medical Center Research Institute

Completed

Submucosal Injection EMR vs. Underwater EMR for Colorectal Polyps (IvU)

Colonic Polyps | Rectal Polyps

United States
California Pacific Medical Center Research Institute

Completed

Biochemotherapy and Bevacizumab Followed by Consolidation Therapy With Ipilimumab for Metastatic Melanoma (BBI)

Metastatic Melanoma

United States
California Pacific Medical Center Research Institute

Completed

Endoscopic Ultrasound Versus Endoscopic Retrograde Cholangiopancreatography (ERCP) Tissue Sampling for the Diagnosis of Suspected Pancreatico-Biliary Cancer

Jaundice | Bile Duct Obstruction | Pancreaticobiliary Cancers

United States
California Pacific Medical Center Research Institute

Completed

A Pilot Trial of Modafinil for Treatment of Methamphetamine Dependence

Methamphetamine Addiction

United States
California Pacific Medical Center Research Institute

Completed

Study of Naltrexone for Methamphetamine Addiction

Methamphetamine Dependence

United States
California Pacific Medical Center Research Institute

Completed

Role of Serotonin in Acute and Subacute MDMA Effects

MDMA Mechanism of Action

United States
California Pacific Medical Center Research Institute

Completed

Proactive Ethics Intervention to Improve Intensive Care Unit (ICU) Care (PEI)

Intensive Care Unit Days

United States
Parkinson's Disease Research, Education, and Clinical...

Completed

Laser Light Visual Cueing for Freezing of Gait in Parkinson's Disease

Parkinson Disease

United States
California Pacific Medical Center Research Institute
Pfizer

Withdrawn

A Phase II Trial of Sunitinib and Nivolumab for KIT-mutated Advanced Melanoma

Melanoma

United States
Pacific Parkinson's Research Centre
University of British Columbia; Oregon Health and Science University; University... and other collaborators

Recruiting

The GBA Multimodal Study in Parkinson's Disease

Parkinson Disease | Gaucher Disease | GBA Gene Mutation

United States, Canada
California Pacific Medical Center Research Institute
Creare, Inc.

Completed

Adherence Monitoring For Substance Abuse Clinical Trials

Medication Adherence

United States
California Pacific Medical Center Research Institute
Genentech, Inc.

Completed

A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis

Chronic Focal Encephalitis | Rasmussen's Encephalitis

United States
California Pacific Medical Center Research Institute
Novartis Pharmaceuticals

Completed

Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic (MYFIIRP)

Renal Transplantation

United States
California Pacific Medical Center Research Institute
Creare, Inc.

Unknown

Comparison of Methamphetamine-Dependent and Healthy Volunteers Using a Web-Enabled Cognitive Neuropsychological Evaluation System (5I)

Methamphetamine Dependence

United States
California Pacific Medical Center Research Institute
M.D. Anderson Cancer Center

Recruiting

Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation

Metastatic Melanoma

United States
Texas Cardiac Arrhythmia Research Foundation
California Pacific Medical Center

Unknown

Does Atrial Fibrillation (AF) Termination Without Additional Ablation Influence Outcome? (TARGET)

Atrial Fibrillation

United States
Texas Cardiac Arrhythmia Research Foundation
California Pacific Medical Center

Unknown

PV Reconnection After PVAI at Different Power Settings and Adenosine Provocation (ZODIAC)

Paroxysmal Atrial Fibrillation

United States
James BOYD MD
Michael J. Fox Foundation for Parkinson's Research; Philipps University Marburg... and other collaborators

Unknown

Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease (NIC-PD)

Parkinson's Disease

United States, Germany
Clinical Nutrition Research Centre, Singapore
Glico Asia Pacific Pte Ltd

Completed

To Study the Effects of Co-ingesting Different Forms of Almond, Almond Paste, Fibre, and Almond Phytochemicals With Bread on Postprandial Glucose and Insulin Profiles

Cardiovascular Diseases | Metabolic Disease

Singapore
Clinical Nutrition Research Centre, Singapore
Cerebos Asia Pacific Pte Ltd

Completed

Glycemic Response of Co-ingesting Carbohydrate and Amino Acids

Metabolic Diseases
Radboud University Medical Center
Michael J. Fox Foundation for Parkinson's Research

Completed

PERsonalized SPEeCh Therapy for actIVE Conversation (PERSPECTIVE)

Parkinson Disease

Netherlands
Rush University Medical Center
Michael J. Fox Foundation for Parkinson's Research

Terminated

Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease (TOP-DYSK)

Idiopathic Parkinson's Disease | Drug Induced Dyskinesia

United States
Dartmouth-Hitchcock Medical Center
Michael J. Fox Foundation for Parkinson's Research

Completed

Prism Adaptation Treatment of Parkinson's Disease

Parkinson

United States
California Pacific Medical Center Research Institute
University of Pittsburgh; Duke University; National Institute on Aging (NIA); University... and other collaborators

Recruiting

Trial of Parkinson's And Zoledronic Acid (TOPAZ)

Parkinson Disease | Osteoporosis | Parkinsonism | Multiple System Atrophy | Progressive Supranuclear Palsy | Parkinson's Disease and Parkinsonism | Dementia With Lewy Bodies | Atypical Parkinsonism | Vascular Parkinsonism

United States
Radboud University Medical Center
Michael J. Fox Foundation for Parkinson's Research

Completed

Multiple N-of-1 Trials of (Intermittent) Hypoxia Therapy in Parkinson's Disease (TALISMAN)

Parkinson Disease | Effect of Drug

Netherlands
Muhammad Ali Parkinson Research Center
Barrow Neurological Foundation

Unknown

Parkinson's Disease Registry of the Muhammad Ali Parkinson Center

Parkinson's Disease

United States
Rush University Medical Center
Michael J. Fox Foundation for Parkinson's Research

Completed

Validation of Dyskinesia Rating Scales

Parkinson's Disease

United States, Austria, Canada, France
Maastricht University Medical Center
Michael J. Fox Foundation for Parkinson's Research

Completed

Cognitive Behavioural Therapy for Anxiety Disorders in PD

Parkinson's Disease | Generalized Anxiety Disorder | Social Phobia

France, Netherlands
Rush University Medical Center
Michael J. Fox Foundation for Parkinson's Research

Completed

Improve Speech Using an In-the-ear Device in Parkinson's Disease (MJFFSpeech)

Parkinson's Disease | Dysarthria

United States
University of Aarhus
Stanford University; California Pacific Medical Center Research Institute

Terminated

Towards Individualized Deep Brain Stimulation Treatment of Chronic Neuropathic Pain (DBSforPain)

Neuralgia

Denmark
California Pacific Medical Center Research Institute
Children's Mercy Hospital Kansas City

Withdrawn

The Impact of Genetic Variation in CYP2D6 on the Pharmacokinetics and Pharmacodynamics of Methamphetamine

Methamphetamine Metabolism, CYP2D6 Genotype

United States

Clinical Trials Sponsored by Pacific Parkinson's Research Centre

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations